Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by N0taP00pon May 06, 2023 1:18am
200 Views
Post# 35434346

RE:RE:RE:RE:RE:RE:RE:RE:Finances

RE:RE:RE:RE:RE:RE:RE:RE:FinancesGreat perspectives, Slayer. There's  blood and sweat for sure to get us this far. Can't fault that. However, I feel there's a point at which you may need an industry veteran to take this forward. Someone that is detached from the science and focuses on capital, industry and shareholder outreach, operations (including manufacturing and procurement), funding and priorities for execution of other initiatives, etc. Same for the BOD.  There will be a time to think big.  BTD is certainly one of those milestones.  Hope it's Q3. And hope they raise only the bare minimum needed. They will need to, anytime now.  If they're fairly confident about BTD, a reverse split strategy (with warrant acceleration) might make sense. You will have more options to raise money when your price is not at penny levels. 
<< Previous
Bullboard Posts
Next >>